JAK1 Inhibitor INCB054707 for Hidradenitis Suppurativa JAK1 Inhibitor INCB054707 for Hidradenitis Suppurativa

Review the safety and efficacy findings from two phase II studies for the JAK1 inhibitor INCB054707 in the treatment of moderate-to-severe hidradenitis suppurativa.The British Journal of Dermatology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news